Aloxy Capsule

Introduction

Aloxy is a prescription medication that contains the active ingredient Palonosetron. It is available under the brand name Aloxy. This medication is primarily used to prevent nausea and vomiting caused by cancer chemotherapy.

Uses

Aloxy is prescribed to patients who are undergoing cancer chemotherapy and are at risk of experiencing nausea and vomiting as a side effect. It helps to prevent these symptoms and improve the overall comfort and well-being of patients during their treatment.

Dosage and Administration

The recommended dosage of Aloxy is determined by your healthcare provider based on various factors such as the type of chemotherapy you are receiving and your individual response to treatment. Follow your healthcare provider’s instructions regarding the dosage and schedule of administration.

Aloxy is typically taken orally, with or without food. Swallow the capsule whole with a glass of water. Do not crush, chew, or open the capsule, as it may affect the way the medication is released in your body.

Mechanism of Action

Palonosetron, the active ingredient in Aloxy, belongs to a class of medications known as serotonin 5-HT3 receptor antagonists. It works by blocking the action of serotonin, a natural substance in the body that can cause nausea and vomiting. By inhibiting the effects of serotonin, Aloxy helps to prevent chemotherapy-induced nausea and vomiting.

Side Effects

Common side effects may include headache, constipation, diarrhea, dizziness, and fatigue. These side effects are usually mild and temporary.

However, if you experience any serious side effects such as severe allergic reactions, chest pain, irregular heartbeat, or signs of serotonin syndrome (such as agitation, hallucinations, rapid heartbeat, fever, muscle stiffness), seek medical attention immediately.

Drug Interactions

Aloxy may interact with certain medications, including other medications that affect serotonin levels in the body. Inform your healthcare provider about all the medications you are currently taking, including prescription drugs, over-the-counter medications, and herbal supplements. They can determine if any potential drug interactions exist and adjust your treatment plan accordingly.

Precautions

Before taking Aloxy, inform your healthcare provider about any medical conditions you have, especially if you have a history of heart problems, liver disease, or any allergies. Additionally, inform your healthcare provider about all the medications you are currently taking to avoid any potential interactions.

Aloxy is not recommended for use in pregnant or breastfeeding women, unless specifically prescribed by a healthcare provider.

Storage

Store Aloxy at room temperature, away from direct sunlight and moisture. Keep it out of the reach of children and pets. Do not use the medication if it has expired or if the packaging is damaged.

Patient Tips

• Take Aloxy exactly as prescribed by your healthcare provider. Do not adjust the dosage or stop taking the medication without consulting your healthcare provider first.
• If you miss a dose, take it as soon as you remember. However, if it is close to the time for your next dose, skip the missed dose and continue with your regular dosing schedule.
• If you have any questions or concerns about Aloxy, talk to your healthcare provider or pharmacist. They can provide you with more information and address any concerns you may have.

Please note that this description, as well as the other content on our website is for educational purposes only. We do not provide medical advice. For specific medical advices, diagnoses and treatment options you should consult with your doctor.

References

• Akynzeo 300 mg/0.5 mg hard capsules (Health Professionals SmPC) Available at:
• Palonosetron injection (Drugs.com) [Accessed 1 Jun. 2024] (online) Available at:
• fosnetupitant-palonosetron solution, reconstituted (recon soln) (RX) [Accessed 22 Jun. 2024] (online) Available at:
• Palonosetron Injection (MedlinePlus) [Accessed 24 Jun. 2024] (online) Available at:
• Siddiqui MA, Scott LJ. Palonosetron. Drugs. 2004;64(10):1125-32; discussion 1133-4. doi: 10.2165/00003495-200464100-00006. [Accessed 29 Jun. 2024] Available at: